Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

Related Citations for PubMed (Select 23710492)

1.

The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.

Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group.

JAMA Ophthalmol. 2013 Apr;131(4):422-9.

2.

Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR.

Arch Ophthalmol. 2010 Jun;128(6):672-8. doi: 10.1001/archophthalmol.2010.102.

3.

Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.

Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group.

Ophthalmology. 2014 Aug;121(8):1495-500.e1. doi: 10.1016/j.ophtha.2014.03.004. Epub 2014 Apr 16.

PMID:
24746358
4.

Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.

Arora R, Gupta D, Goyal J, Kaur R.

Clin Experiment Ophthalmol. 2011 Jul;39(5):434-40. doi: 10.1111/j.1442-9071.2010.02473.x. Epub 2011 Jun 28.

PMID:
21105974
5.

Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.

Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM.

Cornea. 2012 Jun;31(6):662-7. doi: 10.1097/ICO.0b013e31823f8ae0.

6.

Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.

Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM.

Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716.

7.

Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.

Sharma N, Chacko J, Velpandian T, Titiyal JS, Sinha R, Satpathy G, Tandon R, Vajpayee RB.

Ophthalmology. 2013 Apr;120(4):677-81. doi: 10.1016/j.ophtha.2012.09.023. Epub 2012 Dec 12.

PMID:
23246119
8.

In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Cevallos V, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group.

Am J Ophthalmol. 2014 Feb;157(2):318-26. doi: 10.1016/j.ajo.2013.10.004. Epub 2013 Oct 22.

9.

Voriconazole for fungal corneal ulcers.

Parchand S, Gupta A, Ram J, Gupta N, Chakrabarty A.

Ophthalmology. 2012 May;119(5):1083. doi: 10.1016/j.ophtha.2011.11.034. No abstract available.

PMID:
22551602
10.

Management of tunnel fungal infection with voriconazole.

Jhanji V, Sharma N, Mannan R, Titiyal JS, Vajpayee RB.

J Cataract Refract Surg. 2007 May;33(5):915-7.

PMID:
17466872
11.

The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.

Siatiri H, Daneshgar F, Siatiri N, Khodabande A.

Cornea. 2011 Aug;30(8):872-5. doi: 10.1097/ICO.0b013e3182100993.

PMID:
21448063
12.

Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.

Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB.

Br J Ophthalmol. 2011 Dec;95(12):1735-7. doi: 10.1136/bjo.2010.192815. Epub 2011 Mar 31.

PMID:
21454381
13.

Predictors of outcome in fungal keratitis.

Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, Sy A, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Porco TC.

Eye (Lond). 2012 Sep;26(9):1226-31. doi: 10.1038/eye.2012.99. Epub 2012 Jun 29.

14.

Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.

Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D.

Ann Pharmacother. 2009 Jun;43(6):1139-42. doi: 10.1345/aph.1M008. Epub 2009 May 12.

PMID:
19435962
15.

The successful medical treatment of a case of Paecilomyces lilacinus keratitis.

Wu PC, Lai CH, Tan HY, Ma DH, Hsiao CH.

Cornea. 2010 Mar;29(3):357-8. doi: 10.1097/ICO.0b013e3181af7626.

PMID:
20098311
16.

[Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].

Kalkan Akçay E, Açıkgöz ZC, Can ME, Celikbilek N, Dereli Can G, Cağıl N.

Mikrobiyol Bul. 2013 Oct;47(4):727-33. Turkish.

17.

Risk factors for treatment outcome in fungal keratitis.

Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M.

Ophthalmology. 2006 Apr;113(4):526-30.

PMID:
16581414
18.

Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.

Pariseau B, Nehls S, Ogawa GS, Sutton DA, Wickes BL, Romanelli AM.

Cornea. 2010 Feb;29(2):152-8. doi: 10.1097/ICO.0b013e3181ae2575.

PMID:
20023588
19.

Alternaria and paecilomyces keratitis associated with soft contact lens wear.

Yildiz EH, Ailani H, Hammersmith KM, Eagle RC Jr, Rapuano CJ, Cohen EJ.

Cornea. 2010 May;29(5):564-8. doi: 10.1097/ICO.0b013e3181ba0cde.

PMID:
20335812
20.

Intracameral and topical voriconazole for fungal corneal endoexudates.

Mittal V, Mittal R.

Cornea. 2012 Apr;31(4):366-70. doi: 10.1097/ICO.0b013e318233f0a8.

PMID:
22410613
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk